Insider · CIK 0001384243

Quart Barry D

Reports to the SEC for 5 companies · LONDON

sec.gov

Transactions

Companies

Filings

CIK

0001384243

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-19	KNSAKiniksa Pharmaceuticals International, plcG Gift	Director	GGift	−2,600 sh	—	—	12,745
2026-05-29	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director	MExercise/Conversion	+2,799 sh	—	—	15,345
2026-05-29	KNSAKiniksa Pharmaceuticals International, plc · Share OptionA Award	Director	AAward	+12.2K sh	—	—	12,185
2026-05-29	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitsA Award	Director	AAward	+2,026 sh	—	—	2,026
2026-05-29	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,799 sh	—	—	0
2026-04-28	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director	MExercise/Conversion	+13.1K sh	$14.33	+$188K	25,645
2026-04-28	KNSAKiniksa Pharmaceuticals International, plcS Sale	Director	SSale	−13.1K sh	$50.10	−$656K	12,546
2026-04-28	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	Director	MExercise/Conversion	−13.1K sh	—	—	13,237
2026-04-06	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director	MExercise/Conversion	+6,901 sh	$14.33	+$98.9K	19,447
2026-04-06	KNSAKiniksa Pharmaceuticals International, plcS Sale	Director	SSale	−6,901 sh	$50.00	−$345K	12,546
2026-04-06	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	Director	MExercise/Conversion	−6,901 sh	—	—	26,336
2026-02-12	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director	MExercise/Conversion	+2,690 sh	$15.47	+$41.6K	15,236
2026-02-12	KNSAKiniksa Pharmaceuticals International, plcS Sale	Director	SSale	−2,690 sh	$45.00	−$121K	12,546
2026-02-12	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	Director	MExercise/Conversion	−2,690 sh	—	—	0
2026-02-10	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director	MExercise/Conversion	+110 sh	$15.47	+$1,701.7	12,656
2026-02-10	KNSAKiniksa Pharmaceuticals International, plcS Sale	Director	SSale	−110 sh	$45.00	−$4,950	12,546
2026-02-10	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	Director	MExercise/Conversion	−110 sh	—	—	2,690
2026-02-04	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director	MExercise/Conversion	+2,602 sh	$15.47	+$40.3K	15,148
2026-02-04	KNSAKiniksa Pharmaceuticals International, plcS Sale	Director	SSale	−2,602 sh	$45.02	−$117K	12,546
2026-02-04	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	Director	MExercise/Conversion	−2,602 sh	—	—	2,800
2026-02-03	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director	MExercise/Conversion	+12.5K sh	$15.47	+$194K	25,074
2026-02-03	KNSAKiniksa Pharmaceuticals International, plcS Sale	Director	SSale	−12.5K sh	$45.27	−$567K	12,546
2026-02-03	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	Director	MExercise/Conversion	−12.5K sh	—	—	5,402
2026-02-02	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director	MExercise/Conversion	+830 sh	$15.47	+$12.8K	13,376
2026-02-02	KNSAKiniksa Pharmaceuticals International, plcS Sale	Director	SSale	−830 sh	$45.00	−$37.4K	12,546
2026-02-02	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	Director	MExercise/Conversion	−830 sh	—	—	17,930
2025-12-15	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director	MExercise/Conversion	+20.1K sh	$10.36	+$209K	32,675
2025-12-15	KNSAKiniksa Pharmaceuticals International, plcS Sale	Director	SSale	−20.1K sh	$41.51	−$836K	12,546
2025-12-15	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	Director	MExercise/Conversion	−20.1K sh	—	—	0
2025-06-11	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director	MExercise/Conversion	+12.3K sh	$3.80	+$46.9K	24,882
2025-06-11	KNSAKiniksa Pharmaceuticals International, plcS Sale	Director	SSale	−12.3K sh	$30.39	−$375K	12,546
2025-06-11	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	Director	MExercise/Conversion	−12.3K sh	—	—	0
2025-06-10	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director	MExercise/Conversion	+8,212 sh	$3.80	+$31.2K	20,758
2025-06-10	KNSAKiniksa Pharmaceuticals International, plcS Sale	Director	SSale	−8,212 sh	$30.36	−$249K	12,546
2025-06-10	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	Director	MExercise/Conversion	−8,212 sh	—	—	12,336
2025-06-09	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director	MExercise/Conversion	+6,900 sh	$3.80	+$26.2K	19,446
2025-06-09	KNSAKiniksa Pharmaceuticals International, plcS Sale	Director	SSale	−6,900 sh	$30.26	−$209K	12,546
2025-06-09	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	Director	MExercise/Conversion	−6,900 sh	—	—	20,548
2025-06-05	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director	MExercise/Conversion	+3,173 sh	—	—	12,546
2025-06-05	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,173 sh	—	—	0
2025-06-03	KNSAKiniksa Pharmaceuticals International, plc · Share OptionA Award	Director	AAward	+16.8K sh	—	—	16,798
2025-06-03	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitsA Award	Director	AAward	+2,799 sh	—	—	2,799
2024-06-06	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director	MExercise/Conversion	+4,373 sh	—	—	9,373
2024-06-06	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,373 sh	—	—	0
2024-06-05	KNSAKiniksa Pharmaceuticals International, plc · Share OptionA Award	Director	AAward	+19K sh	—	—	19,040
2024-06-05	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitsA Award	Director	AAward	+3,173 sh	—	—	3,173
2023-06-29	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	—	—	5,000
2023-06-29	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	0
2023-06-06	KNSAKiniksa Pharmaceuticals International, plc · Share OptionA Award	Director	AAward	+26.2K sh	—	—	26,236
2023-06-06	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitsA Award	Director	AAward	+4,373 sh	—	—	4,373

Recent filings

Accepted (ET)
Aug 214
Quart Barry D0001384243-26-000014
SEC(opens sec.gov)
Jun 24
Quart Barry D0001384243-26-000012
SEC(opens sec.gov)
Apr 294
Quart Barry D0001384243-26-000010
SEC(opens sec.gov)
Apr 84
Quart Barry D0001384243-26-000008
SEC(opens sec.gov)
Feb 124
Quart Barry D0001384243-26-000004
SEC(opens sec.gov)
Feb 44
Quart Barry D0001384243-26-000002
SEC(opens sec.gov)

Companies

Address

C/O KINIKSA PHARMACEUTICALS INT'L 105 PICCADILLY, SECOND FLOOR

LONDON, W1J 7NJ